Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2547-2549, July 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Stancel, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Stancel, G. M.

Selective Inhibition of Estrogen-regulated Gene Expression in Vivo by the Pure Antiestrogen ICI 182,7801

Salman M. Hyder2, Constance Chiappetta, Lata Murthy and George M. Stancel

Departments of Integrative Biology, Pharmacology, and Physiology [S. M. H., C. C., G. M. S.] and Obstetrics, Gynecology, and Reproductive Sciences [S. M. H.], University of Texas Health Sciences Center, Houston, Texas 77225, and Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030 [L.M.]

Estrogen-stimulated cell proliferation is thought to be mediated by the induction of growth-regulatory factors. Abnormal regulation of such factors may be associated with tumorigenesis. Two such factors, vascular endothelial growth factor and c-fos, are rapidly induced in the uterus by estrogens. We show that the induction of these transcripts by 17ß-estradiol or tamoxifen is selectively blocked by the pure antiestrogen ICI 182,780 in a dose-dependent manner. This indicates that induction of the two genes requires different levels of estrogen receptor or that their induction occurs by different mechanisms. This suggests that selective dose-dependent antagonism of estrogen-dependent transcription may be possible in target tissues and tumors.

1 This research was supported by a Grant-in-Aid from the American Heart Association, Texas Affiliate, and by NIH Grants HD-08615 and ES-06995.

2 To whom requests for reprints should be addressed, at Department of Integrative Biology, Pharmacology, and Physiology, University of Texas Medical School, P. O. Box 20708, 6431 Fannin Street, Houston, TX 77225. Phone: (713) 500-7459; Fax: (713) 500-7455; E-mail: shyder@farmr1.med.uth.tmc.edu.

Received 4/ 2/97. Accepted 5/15/97.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
X. Long, M. Fan, R. M. Bigsby, and K. P. Nephew
Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-{alpha}-dependent and estrogen receptor-{alpha}-independent mechanisms
Mol. Cancer Ther., July 1, 2008; 7(7): 2096 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Fritah, C. Saucier, O. De Wever, M. Bracke, I. Bieche, R. Lidereau, C. Gespach, S. Drouot, G. Redeuilh, and M. Sabbah
Role of WISP-2/CCN5 in the Maintenance of a Differentiated and Noninvasive Phenotype in Human Breast Cancer Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 1114 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Belguise, S. Guo, and G. E. Sonenshein
Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor {alpha} Expression Reversing Invasive Phenotype of Breast Cancer Cells
Cancer Res., June 15, 2007; 67(12): 5763 - 5770.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S M Hyder
Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 667 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. H. Wang, N. H. Afdhal, and D. Q-H. Wang
Overexpression of estrogen receptor {alpha} increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice
J. Lipid Res., April 1, 2006; 47(4): 778 - 786.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. D. KOOS, A. A. KAZI, M. S. ROBERSON, and J. M. JONES
New Insight into the Transcriptional Regulation of Vascular Endothelial Growth Factor Expression in the Endometrium by Estrogen and Relaxin
Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 233 - 247.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Vonnahme and S. P. Ford
Differential Expression of the Vascular Endothelial Growth Factor-Receptor System in the Gravid Uterus of Yorkshire and Meishan Pigs
Biol Reprod, July 1, 2004; 71(1): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Masuno, S. Okamoto, J. Iwanami, K. Honda, T. Shiosaka, T. Kidani, K. Sakayama, and H. Yamamoto
Effect of 4-Nonylphenol on Cell Proliferation and Adipocyte Formation in Cultures of Fully Differentiated 3T3-L1 Cells
Toxicol. Sci., October 1, 2003; 75(2): 314 - 320.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
O. A. Sukocheva, L. Wang, N. Albanese, S. M. Pitson, M. A. Vadas, and P. Xia
Sphingosine Kinase Transmits Estrogen Signaling in Human Breast Cancer Cells
Mol. Endocrinol., October 1, 2003; 17(10): 2002 - 2012.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B.A. Roopa, A. Loganath, and K. Singh
The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium
Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. R. Nayak and R. M. Brenner
Vascular Proliferation and Vascular Endothelial Growth Factor Expression in the Rhesus Macaque Endometrium
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1845 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. F. Robertson, R. I. Nicholson, N. J. Bundred, E. Anderson, Z. Rayter, M. Dowsett, J. N. Fox, J. M. W. Gee, A. Webster, A. E. Wakeling, et al.
Comparison of the Short-Term Biological Effects of 7{alpha}-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17{beta}-diol (Faslodex) versus Tamoxifen in Postmenopausal Women with Primary Breast Cancer
Cancer Res., September 1, 2001; 61(18): 6739 - 6746.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Krumenacker, S. M. Hyder, and F. Murad
Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus
PNAS, January 16, 2001; 98(2): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. K. Osborne and S. A. W. Fuqua
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
J. Clin. Oncol., September 17, 2000; 18(17): 3172 - 3186.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Garcia, D. Lacasa, and Y. Giudicelli
Estradiol Stimulation of c-fos and c-jun Expressions and Activator Protein-1 Deoxyribonucleic Acid Binding Activity in Rat White Adipocyte
Endocrinology, August 1, 2000; 141(8): 2837 - 2846.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Hyder, Z. Nawaz, C. Chiappetta, and G. M. Stancel
Identification of Functional Estrogen Response Elements in the Gene Coding for the Potent Angiogenic Factor Vascular Endothelial Growth Factor
Cancer Res., June 1, 2000; 60(12): 3183 - 3190.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
E. K. Lobenhofer, G. Huper, J. D. Iglehart, and J. R. Marks
Inhibition of Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase Activity in MCF-7 Cells Prevents Estrogen-induced Mitogenesis
Cell Growth Differ., February 1, 2000; 11(2): 99 - 110.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Hyder, C. Chiappetta, and G. M. Stancel
Synthetic Estrogen 17alpha -Ethinyl Estradiol Induces Pattern of Uterine Gene Expression Similar to Endogenous Estrogen 17beta -Estradiol
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 740 - 747.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. M. Hyder and G. M. Stancel
Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins
Mol. Endocrinol., June 1, 1999; 13(6): 806 - 811.
[Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. M. Saleh and B. J. Connell
Centrally mediated effect of 17beta -estradiol on parasympathetic tone in male rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R474 - R481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. M. Saleh and B. J. Connell
Role of 17beta -estradiol in the modulation of baroreflex sensitivity in male rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R770 - R778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.